Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study

被引:8
作者
Meamar, Rokhsareh [1 ]
Amini, Masoud [2 ]
Aminorroaya, Ashraf [2 ]
Nasri, Maryam [3 ]
Abyar, Majid [2 ]
Feizi, Awat [2 ,4 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Isfahan Clin Toxicol Res Ctr, Esfahan 8174673461, Iran
[2] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, POB 319,Hezar Jerib Ave, Esfahan 8174673461, Iran
[3] Grovemead Hlth Ctr, London NW4 3EB, England
[4] Isfahan Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Esfahan 8174673461, Iran
关键词
Insulin resistance; Metabolic syndrome; Risk; Type 2 diabetes mellitus; Prediabetes; First degree relative; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; FAMILIAL AGGREGATION; GENDER-DIFFERENCES; RISK; OBESITY; ADOLESCENTS; SEX; CHILDHOOD; MELLITUS;
D O I
10.4239/wjd.v11.i5.202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Type 2 diabetes mellitus (T2DM) has high morbidity and mortality worldwide, therefore there is of paramount importance to identify the risk factors in the populations at risk early in the course of illness. A strong correlation between severity of metabolic syndrome (MetS) and HbA1c, fasting insulin and insulin resistance has been reported. Accordingly, the MetS severity score (or MestS Z-score) can potentially be used to predict the risk of T2DM progression over time. AIM To evaluate the association the of MestS Z-score in first degree relatives (FDRs) of T2DM with the risk of prediabetes and type 2 diabetes in future. METHODS A prospective open cohort study was conducted between 2003-2018. At baseline, the sample comprised of 1766 FDRs of patients with T2DM who had a normal glucose tolerance test. Relative risk (RR) and 95% confidence interval were calculated based on logistic regression. The receiver-operator characteristic analysis and area under the curve based on MetS Z-score were used to evaluate the risk of prediabetes and diabetes among the FDR population. RESULTS Baseline MetS Z-scores were associated with the its latest values (P < 0.0001). Compared with individuals who were T2DM free at the end of follow up, those who developed T2DM had higher MetS Z-score at baseline (P < 0.001). In multivariable logistic regression analyses for every unit elevation in MetS Z-score at the baseline, the RR for developing future T2DM and prediabetes was (RR = 1.94, RR = 3.84), (RR = 1.5, RR = 2.17) in total population and female group, respectively (P < 0.05). The associations remained significant after adjusting the potential confounding variables. A cut off value of 0.97 and 0.94 was defined in the receiver-operator characteristic curve based on the MetS Z-score for differentiating female patients with diabetes and prediabetes from the normal population, respectively. CONCLUSION The MetS Z-score was associated with an increased risk of future T2DM. Appropriate interventions at earlier stages for preventing and attenuating MetS effects may be considered as an effective strategy for FDR as at-risk population.
引用
收藏
页码:202 / 212
页数:11
相关论文
共 50 条
  • [21] Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans
    Hwang, You-Cheol
    Jee, Jae-Hwan
    Oh, Eun Young
    Choi, Yoon-Ho
    Lee, Myung-Shik
    Kim, Kwang-Won
    Lee, Moon-Kyu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (03) : 313 - 321
  • [22] Glycemic profile variability as an independent predictor of diabetic retinopathy in patients with type 2 diabetes: a prospective cohort study
    Firouzabadi, Fatemeh Dehghani
    Poopak, Amirhossein
    Samimi, Sahar
    Deravi, Niloofar
    Nakhaei, Pooria
    Sheikhy, Ali
    Moosaie, Fatemeh
    Rabizadeh, Soghra
    Meysamie, Alipasha
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [23] Serum Alanine Transaminase as a Predictor of Type 2 Diabetes Incidence: The Yuport Prospective Cohort Study
    Hatano, Yu
    Inoue, Kazuo
    Kashima, Saori
    Matsumoto, Masatoshi
    Akimoto, Kimihiko
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 251 (03) : 183 - 191
  • [24] Waist circumference glucose, a novel and effective predictor of type 2 diabetes: a prospective cohort study
    Zhao, Xiaofang
    Song, Bei
    Yao, Tianci
    Fan, Haohui
    Liu, Ting
    Gao, Guangyu
    Wang, Kun
    Lu, Weilin
    Liu, Chengyun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [25] A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome
    M. A. Nauck
    J. J. Meier
    A. V. Wolfersdorff
    H. Tillil
    W. Creutzfeldt
    J. Köbberling
    [J]. Acta Diabetologica, 2003, 40 : 163 - 172
  • [26] A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients:: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome
    Nauck, MA
    Meier, JJ
    Wolfersdorff, AV
    Tillil, H
    Creutzfeldt, W
    Köbberling, J
    [J]. ACTA DIABETOLOGICA, 2003, 40 (04) : 163 - 172
  • [27] Diabetes risk among first-degree relatives of patients with type 2 diabetes in Isfahan, Iran
    Janghorbani, Mohsen
    Amini, Masoud
    [J]. OBESITY AND METABOLISM-MILAN, 2009, 5 (3-4): : 114 - 120
  • [28] Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus
    Alawdi, Shawqi H.
    Al-Dholae, Mohammed
    Al-Shawky, Salah
    [J]. FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2024, 5
  • [29] Pancreatic beta cell function and insulin resistance profiles in first-degree relatives of patients with prediabetes and type 2 diabetes
    Herrerias-Garcia, Anaid
    Jacobo-Tovar, Emmanuel
    Hernandez-Robles, Claudia Mariana
    Guardado-Mendoza, Rodolfo
    [J]. ACTA DIABETOLOGICA, 2025, 62 (02) : 253 - 261
  • [30] The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
    Bonora, E
    Targher, G
    Formentini, G
    Calcaterra, F
    Lombardi, S
    Marini, F
    Zenari, L
    Saggiani, F
    Poli, M
    Perbellini, S
    Raffaelli, A
    Gemma, L
    Santi, L
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETIC MEDICINE, 2004, 21 (01) : 52 - 58